Skip to main content
TRDA logo

TRDA · Entrada Therapeutics, Inc.

$6.05 -0.10 (-1.63%) At close · Jul 23
Market Cap
$234.86M
Shares
38.82M

Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.

Short Squeeze Score
53/100
Short interest 5.4% of shares — P75 Days to cover 5.9 — P86 Price vs VWAP -20.6% — P16 Short-volume trend -10.9% — P17 Short interest change +10.4% — P67 Worst FTD 0.00% of shares — P14

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-30). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-06-30 2,111,685 1,913,294 +198,391 5.85
2026-06-15 1,913,294 1,727,002 +186,292 8.00
2026-05-29 1,727,002 1,507,737 +219,265 4.47
2026-05-15 1,507,737 998,352 +509,385 1.55
2026-04-30 998,352 852,247 +146,105 5.48
2026-04-15 852,247 894,152 -41,905 5.53
2026-03-31 894,152 924,265 -30,113 4.70
2026-03-13 924,265 822,864 +101,401 3.50
2026-02-27 822,864 908,901 -86,037 4.81
2026-02-13 908,901 896,142 +12,759 4.65
2026-01-30 896,142 858,462 +37,680 3.13
2026-01-15 858,462 760,344 +98,118 3.93
2025-12-31 760,344 898,798 -138,454 4.37
2025-12-15 898,798 948,628 -49,830 4.87
2025-11-28 948,628 926,483 +22,145 3.75
2025-11-14 926,483 893,790 +32,693 2.66
2025-10-31 893,790 944,223 -50,433 4.78
2025-10-15 944,223 813,393 +130,830 5.49
2025-09-30 813,393 1,055,611 -242,218 1.65
2025-09-15 1,055,611 1,080,683 -25,072 3.79
2025-08-29 1,080,683 1,068,552 +12,131 6.27
2025-08-15 1,068,552 1,145,776 -77,224 3.27
2025-07-31 1,145,776 1,297,778 -152,002 7.79
Showing 1–23 of 23 settlements
Key facts CIK 1689375 CUSIP 29384C108 13F (30d) 14 filings 14 filers Visit website Investor relations